Adagio System
Atrial Fibrillation (Paroxysmal and Persistent)
Phase 3Active
Key Facts
Indication
Atrial Fibrillation (Paroxysmal and Persistent)
Phase
Phase 3
Status
Active
Company
About Adagio Medical
Adagio Medical is a clinical-stage medical device innovator targeting the large and growing market for atrial fibrillation ablation. Its core technology is the Adagio System, which utilizes an ultra-low temperature cryoablation (ULTC) approach with a linear catheter designed to create durable, continuous lesions in cardiac tissue. The company is advancing its lead program through clinical studies, positioning itself as a potential competitor in the pulsed field ablation (PFA) and cryoablation landscape. Backed by venture capital, Adagio aims to address limitations of current thermal ablation technologies by offering a safer, more effective, and efficient solution for electrophysiologists.
View full company profile